The data that was shared at this ESMO Breast meeting shows that there is potential activity in not only the traditional HER2 positive patients, but also in HER2 expressing patients.” Further ...

At the ESMO congress, the German biotech reported ... "This new dataset further supports the encouraging results we have seen for BNT211 to date," commented Prof Özlem Türeci, BioNTech's chief ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...